Back to search

Article

A PARP inhibitor, rucaparib, improves cardiac dysfunction in <i>ADP-ribose-acceptor hydrolase 3</i> ( <i>Arh3</i> ) deficiency

2023-02-07

Abstract excerpt

<h4>Aims</h4> Patients with ADP-ribose-acceptor hydrolase 3 ( ARH3 ) deficiency exhibit stress-induced childhood-onset neurodegeneration with ataxia and seizures (CONDSIAS). ARH3 degrades protein-linked poly(ADP- ribose) (PAR) synthesized by poly(ADP-ribose)polymerase (PARP)-1 during oxidative stress, leading to cleavage of the ADP-ribose linked to protein. ARH3 deficiency leads to excess accumulation of PAR,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f220be5c-b4c8-58de-ae74-a71e890ed03f
DOI
10.1101/2023.02.07.527369
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A PARP inhibitor, rucaparib, improves cardiac dysfunction in <i>ADP-ribose-acceptor hydrolase 3</i> ( <i>Arh3</i> ) deficiencyDOI 10.1101/2023.02.07.527369
Select a neighboring publication to make it the new centre.